top of page

Search Results

52 results found for "Ben Jones"

Programs (1)

View All

Posts (37)

  • 📰 GPCR Weekly News, June 3 to June 9, 2024

    Deadline 1st round priority: June 24th / 2nd round: July 22th Do you have an artistic side? Let’s dive into the Classified GPCR News from June 3rd to June 9th, 2024. GPCRs and Emotional Pain: Exploring Non-Narcotic Pathways to Relief GPCR Events, Meetings, and Webinars June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling Networks June 25 - 29, 2024 | FENS

  • Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024

    tagging and interrogation of GPCR co-internalization Kilian Roßmann , Ramona Birke , Joshua Levitz , Ben Jones , Johannes Broichhagen Design of allosteric modulators that change GPCR G protein subtype selectivity 2025 | AACR Annual Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 20 - 22, 2025 | SLAS Europe 2025 June

View All

Other Pages (14)

  • Ep 136 with Murat Tunaboylu & Ben Holland

    Ep 136 with Murat Tunaboylu & Ben Holland Dr. GPCR Podcast << Back to podcast list Murat Tunaboylu & Ben Holland !

  • Ep 52 with Dr. Benjamin Myers

    Benjamin Myers Ben Myers is an assistant professor at the University of Utah School of Medicine in Salt Ben’s research focuses on Smoothened and other class F GPCRs which play essential roles in embryonic More recently, Ben’s lab has begun studying GPCR signaling pathways that operate within the primary cilium Ben studied developmental and cancer signaling as a postdoctoral fellow with Philip Beachy at Stanford Prior to that, Ben received his Ph.D. from UCSF in 2008, where he worked with David Julius on the structure

  • Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer

    ’s research interests lies in the elucidation of signal transduction pathways in cancer, immune and bone The Rottapel lab has shown that 3BP2 has pleiotrophic function controlling bone homeostasis, immune cell

View All
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
bottom of page